HS 6403-99-30-00 – Other women's footwear, valued at $30 or more per pair

Tariff data as of T2026-2, effective Sept 1, 2026, last verified Oct 21, 2026

Footwear with outer soles of rubber, plastics, leather or composition leather and uppers of leather. › Other › Other women's footwear, valued at $30 or more per pair

MFN duty rate

11 %

GST

5%

Unit of measure

PAR

Other women's footwear, valued at $30 or more per pair

Estimate duty & taxes · Get classification help

Preferential tariff rates

• CPTPP – United Kingdom (CPUKT): Free
• UST/CUSMA (US): Free
• Norway (NT): Free
• UK: Free
• Jordan (JT): Free
• Switzerland–Liechtenstein (SLT): Free
• CETA: Free
• New Zealand: 6.5%
• Costa Rica (CRT): Free
• Chile: Free
• Australia: 6.5%
• LDCT: Free
• Honduras (HNT): Free
• Colombia: Free
• Korea: Free
• CPTPP: Free
• MXT/CUSMA (Mexico): Free
• Peru: Free
• Ukraine: Free
• Iceland: Free
• Panama (PAT): Free
• Israel (CIAT): Free

Preference requires qualifying origin and origin proof or certification.

Frequently asked questions

What is the MFN duty on Other women's footwear, valued at $30 or more per pair (HS 6403-99-30-00)?

The T2026-2 MFN rate for tariff item 6403.99.30 is 11%. Specific or compound rates require manual calculation. Classification and origin must be verified with CBSA.

What is the duty on HS 6403-99-30-00 from the US?

Qualifying US-origin goods with origin proof use UST/CUSMA at Free. This item is not on any US surtax schedule in force in TariffPlus surtax data (checked against CBSA). GST/HST and any applicable personal-import provincial tax are additional.

Which trade agreement rates apply to HS 6403-99-30-00?

CPTPP – United Kingdom (CPUKT): Free; UST/CUSMA (US): Free; Norway (NT): Free; UK: Free; Jordan (JT): Free; Switzerland–Liechtenstein (SLT): Free; CETA: Free; New Zealand: 6.5%; Costa Rica (CRT): Free; Chile: Free; Australia: 6.5%; LDCT: Free; Honduras (HNT): Free; Colombia: Free; Korea: Free; CPTPP: Free; MXT/CUSMA (Mexico): Free; Peru: Free; Ukraine: Free; Iceland: Free; Panama (PAT): Free; Israel (CIAT): Free. Preferential treatment requires qualifying origin and certification. Rates are informational; CBSA is authoritative.